{
  "docId": "019dd923-5f69-752d-a9b9-7febd653c093",
  "docSlug": "ZFP1QxeNpCfFhbrzYAWi",
  "documentTitle": "See the 18-slide pitch deck a genetics startup used to raise $100 million and explore the 'dark side' of the genome",
  "authorId": "Pitchdecks",
  "authorName": "CAMP4",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 13,
  "pageCount": 18,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 18,
  "notes": "The diagram illustrates the genetic mechanism (ASOs targeting NAT to release SCN1A). The chart shows a clear dose-response relationship.",
  "elementsJson": [
    "headline_text",
    "action_title",
    "callout_box",
    "process_diagram",
    "bar_chart_grouped",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5f69-752d-a9b9-7febd653c093/13",
  "deckHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093",
  "deckJsonHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093.json",
  "deckAnchorHref": "/decks/019dd923-5f69-752d-a9b9-7febd653c093#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.04,
        "y": 0.165
      },
      "kind": "callout",
      "text": "Inhibiting the NAT regulating the SCN1A gene",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c900aa8-bac5-4493-98b2-fb12f0893918",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.51,
        "y": 0.165
      },
      "kind": "callout",
      "text": "CMP-SCN-001 upregulates SCN1A in human cell lines and patient fibroblasts*",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a8ad973-84a7-4c96-a0a9-c645f3a7403b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.35,
        "x": 0.57,
        "y": 0.34
      },
      "kind": "chart",
      "text": "Dose dependent upregulation of SCN1A mRNA",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c9cda0c-db41-4d03-b477-cfd2404e9eab",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.57,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "*similar response seen across different patient fibroblast cells",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9daba6e8-1ab2-4299-85bf-5db3887a559f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.45,
        "x": 0.04,
        "y": 0.35
      },
      "kind": "image",
      "text": "Diagram showing Chr 2, SCN1A gene, NAT, and ASOs",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9b75a5e-3b69-4585-b214-90e1f41ccfda",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "SCN1A mRNA levels",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-abe4-75dc-a303-f0f9a197f700",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.05,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "Hsiao et al, eBiomedicine, 2016",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4eef70bd-c2d7-491d-b991-573dcd0b1fb1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.02,
        "y": 0.05
      },
      "kind": "title",
      "text": "Our approach to Dravet: remove the brakes on the healthy SCN1A gene",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ceec725-64c9-4cad-9f8f-ee95ab04540d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.02,
        "y": 0.11
      },
      "kind": "title",
      "text": "CMP-SCN-001 development candidate for Dravet Syndrome",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "48ad176a-544f-4eb2-a7aa-43180cae6580",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 13,
      "beatId": "83232633-6fc0-4a1b-a0a5-fe516b3d8578",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The deck presents CAMP4's approach to Dravet and the potential solution offered by their RAP (p13-18)",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 12,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ad824c9f-ade3-46dc-85b3-9835f23c9a9a",
      "evidence": "The deck presents the market opportunity for CAMP4's targeted SCN1A upregulation approach (p16)",
      "position": 0,
      "objective": "Highlight the cost of inaction for Dravet Syndrome patients",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}